BioSpace News Archive

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces the closing of its registered direct offering of American Depositary Shares on the NASDAQ Global Market.

AstraZeneca, a front-runner in the race for a COVID vaccine, recently announced that they would begin enrolling for their Phase II/III clinical trial in Mid-August.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Medicure Inc., a cardiovascular pharmaceutical company, will release financial results for the quarter ended June 30, 2020 on Tuesday, August 11, 2020.

BioSig Technologies, Inc.’s subsidiary, ViralClear Pharmaceuticals, Inc., announced the addition of Dr. Michael J. Sofia to its Scientific Advisory Board.

Bright Path Labs is leveraging TrackWise Digital and Quartic.ai platforms to connect manufacturing insights to QMS for real-time decisions

American Association of Orthopaedic Surgeons President Joseph A. Bosco III, MD, FAAOS, issued the following statement in response to the Centers for Medicare & Medicaid Services’ newly released Calendar Year 2021 Medicare Physician Fee Schedule rule, which proposes to reduce all orthopaedic surgical services by approximately 5%.

Central Texas-based biotechnology startup Industrial Genetics announces the launch of its proprietary genetic testing technology to identify the virus that causes COVID-19, on surfaces and in wastewater.

OPKO Health, Inc. announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 9:00 a.m. Eastern time.

Prothena Corporation plc announced that results from Part 1 of the Phase 2 PASADENA study of prasinezumab in early Parkinson’s disease was selected as an oral Top Abstract presentation at the upcoming virtual International Congress of Parkinson’s Disease and Movement Disorders Society.